Major South Korean pharma companies lose appeal against vaccine cartel fines
Major South Korean pharmaceutical companies — GC Pharmaceutical, Boryung Biopharma and SK Discovery — have lost their appeal to overturn a 2023 antitrust fine imposed by the country’s competition regulator for colluding in...To view the full article, register now.
Already a subscriber? Click here to view full article